Position in NVS
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$209,221
-$22,348 QoQ
Shares Held
1,335
-11.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#1,296
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Owl Creek Wealth Partners LLC holds $3,686,895 across 15 Drug Manufacturers - General names. NVS ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
835 | $1,001,524 | |
| 2 | JNJ |
Johnson & Johnson
|
2,375 | $603,178 | |
| 3 | ABBV |
AbbVie Inc.
|
1,967 | $494,975 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,726 | $350,291 | |
| 5 | AZN |
Astrazeneca PLC
|
1,241 | $235,318 | |
| 6 | NVS |
Novartis AG
This page
|
1,335 | $209,221 | |
| 7 | AMGN |
Amgen Inc
|
484 | $175,266 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,187 | $149,965 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $209,221 | 1,335 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $231,569 | 1,516 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||